2022 Partnership and Innovation Accelerator Pilot Grant Program |
|
2022 PIAP Grant Program Application Is Now Open!
PIAP grants are one-year competitive awards to facilitate collaborations between academic researchers from Rutgers University, Princeton University, and/or New Jersey Institute of Technology with community organizations so they can work together on health research that benefits our communities. Click here to apply.
Deadlines:
November 15, 2021 – Letter of Intent Due
January 1, 2022 – Applications Due *EXTENDED*
March 1, 2022 –Tentative Pilot Start Date
-
Want to know more about the PIAP application process? Click here to watch the 2021 PIAP Program webinar.
-
Don’t have a community partner? Click here for a referral to a community organization in our Network of Networks.
-
Want to make your application stronger? Consider booking a One-on-One Consultation or a Community Engagement Virtual Salon, click here.
|
|
New Jersey Healthcare Essential WoRker Outreach and Education Study - Testing Overlooked Occupations |
|
Phase 1 Publication:
Black and Latinx Community Perspectives on COVID-19 Mitigation Behaviors, Testing and Vaccines
Black and Latinx communities have been disproportionately affected by the COVID-19 pandemic, yet little work has sought to understand their perspectives. This paper aims to explore the experiences of Black and Latinx communities during the pandemic to better understand their perspectives on COVID-19 mitigation behaviors (eg, mask wearing), testing, and vaccines.
To read the full paper on the JAMA Network Open, click here.
|
|
One-on-One Consultations
The CEC helps researchers obtain project-specific input from research, healthcare, community, and patient stakeholders to enhance research design, implementation, and dissemination.
Community Engagement Virtual Salons (CEVS)
CEVS bring researchers together with patients, community members, and health care stakeholders to actively participate in cross-talk. It provides a forum for generating research questions, identifying evidence gaps, and defining outcomes meaningful to patients. To see a CEVS in action, take a look at the summary video featured below.
If you're interested in working with us, click here to learn more.
|
|
The Diabetes LIFEMAP© & Social Determinants of Health (SDOH)
Dr. Shilpa Pai, Dr. David Bleich, and Carmen Wheeler
Rutgers University- Robert Wood Johnson Medical School
March 4rd, 2021
|
|
|
|
|
A Youth-Led Digital Education
Intervention to Improve Adult Blood Pressure
Sara Heinert, PhD
Assistant Professor & Associate Research Director
Department of Emergency Medicine
May 17th, 2021
|
|
|
|
If your research has benefited from one or more NJ ACTS resources, please remember to:
-
Cite our CTSA grant, UL1TR003017, KL2TR003018, or TL1TR003019 in any relevant publications, abstracts, chapters, and/or posters.
-
Submit your publications to PubMed Central (PMC) for compliance with the NIH Public Access Policy.
-
Share your research updates with us by sending an email to: njactscommunity@rwjms.rutgers.edu
|
|
|
|
PRINCETON - New Regional Princeton-led Innovation Hub to Accelerate Tech, Enhance Diversity in Entrepreneurship
Aiming to accelerate the transformation of scientific discoveries into technologies that improve everyday lives, a Princeton University-led consortium of regional universities will form a new innovation network with a $15 million grant from the National Science Foundation (NSF). To read the full story, click here.
|
|
NJIT - Visual Comprehension and Orientation into the COVID-19 CIDO Ontology
The frantic worldwide search for mediations and vaccines for the COVID-19 infection would greatly benefit from a COVID-19 standard reference ontology for this extensive research. Several COVID-19 ontologies exist already. Most of them are accessible through the NCBO BioPortal. The largest is the Coronavirus Infectious Disease Ontology (CIDO) (6,938 concepts in February 2021), which was created to provide a standardized representation of various coronavirus infectious diseases. To read the full article, click here.
|
|
|
|
|
RUTGERS - Family Literacy Program Helps Latino Children and Parents Get Ready for Kindergarten
A family literacy program developed by Manuel Jimenez, MD, MS, FAAP, assistant professor of pediatrics and family medicine and community health, is helping support school readiness for pre-K children in New Brunswick who come from low-income Latino backgrounds. To learn more, click here.
|
|
Community Spotlight
NJ HEROES TOO Partners
|
|
The NJ HEROES TOO project was co-created and co-design by our community and healthcare partners. We will be featuring all 22 of our partners in this section of our Quarterly Newsletter through March 2022.
|
|
Parker Health Group
In 1907, Parker a 501 (c)(3) not-for-profit organization, was founded as a place where people could age in a home-like setting. Since then, Parker has led the way in aging services and has been committed to challenging, changing, and expanding the idea of what it means to grow older in America. Parker Health Group includes 4 nursing homes, an assisted living facility, 2 memory care programs, 2 adult day centers, a post-acute rehabilitation program, a health and wellness center, and several other community-based services for its senior citizens and caregivers. Parker is a diverse community of over 1,000 passionate employees, caregivers, volunteers, thought leaders, researchers, educators and partners leading the way in aging services. All programs include medical, social, personal, emotional, and physical support, which empower personal choice and enrich the lives of every resident, participant, and family member whom they serve. To learn more, click here.
|
|
Partnership for Maternal and Child Health in Northern NJ
The Partnership for Maternal and Child Health of Northern New Jersey was a merger of three state child and maternal health consortia in 2012. Licensed by the New Jersey Department of Health and Senior Services, the Partnership serves as the lead planning agency for maternal and child health services in Northern New Jersey. Our mission is to meet the healthcare needs of women, infants, and children in NJ while coordinating education, outreach, and advocacy through regional planning and collaboration. The consortium conducts extensive community outreach and educational programs for the consumers and health care providers in the state of New Jersey. The Partnership for Maternal and Child Health of Northern New Jersey conducts awareness programs within the community through a variety of ways including small group discussions, special events, health fairs, and consumer-focused newsletters written in various languages, including English and Spanish. To learn more, click here.
|
|
Program for Parents
Programs for Parents is a not-for-profit organization which works to ensure that children get the best possible start in life. They support children, families and childcare providers, in Essex County, through advocacy and action, offering education, referrals, sharing best practices and access to available financial resources. Programs for Parents, Inc., one of the top 10 not-for-profits in New Jersey, works to ensure that children get the best possible start in life. Programs for Parents is now the largest agency of its kind in New Jersey. It has evolved from a childcare resource and referral agency to an organization offering a full range of services, including professional training, technical assistance and home inspections. Furthermore, they serve as the principal advocate for childcare services in Essex County. To learn more, click here.
|
|
Puerto Rican Action Board
The Puerto Rican Action Board (PRAB) is a 501(C)3 nonprofit organization in based New Jersey. PRAB is a comprehensive human services organization that offers early childhood, youth, family, and community services to over 30,000 individuals and families annually in New Brunswick, Middlesex County, and Central New Jersey. PRAB’s mission is to equip diverse individuals and families in Central New Jersey to achieve personal, family, and community development. As the Community Action Agency for Middlesex County West (since 2009), they also address issues of poverty to change people’s lives, bring hope, and improve our local communities. To learn more, click here.
|
|
Robert Wood Johnson University Hospital - RWJBH
In March, 2016, Barnabas Health affiliated the two health systems to form the most comprehensive health system in the state of New Jersey – RWJBarnabas Health. This new organization has a service area covering approximately 5 million people -- more than half of the state's population. The system’s geographic footprint spans Hudson, Essex, Union, Middlesex, Mercer, Somerset, Monmouth and Ocean counties. RWJBarnabas Health’s recent partnership with Rutgers University has made it New Jersey’s largest academic health care system. This collaboration aligns RWJBarnabas Health, New Jersey’s largest health care system; Rutgers, The State University of New Jersey; and Rutgers Health Group. The partnership also aligns RWJBarnabas Health with Rutgers’ education, research, and clinical activities, including those at the Rutgers Cancer Institute of New Jersey and Rutgers University Behavioral Health Care. The system includes 9000 physicians and 16 hospitals, including eleven acute adult care hospitals. To learn more, click here.
|
|
Stay tuned for more Community Spotlights of our NJ HEROES TOO partners in our upcoming Quarterly Newsletter issues.
|
|
|
|
The situation around the current spread of COVID-19 is changing rapidly. We have compiled resource links for the general community highlighting local resources across New Jersey, ways to get involved, and mental and physical wellness. Visit our COVID-19 page for resources for individuals and community partners.
Check out our YouTube channel and blog to stay up to date with COVID-19 related news across the consortium.
|
|
Why this COVID News Could Finally Get Us Back to Normal
A sigh of relief for parents of young children: Pfizer announces its Covid-19 vaccine is safe and generates a 'robust' antibody response for kids age 5-11.
|
|
|
|
|
Why the Unvaccinated Are Unvaccinated
A new report based on a June survey looks at the decision not to get vaccinated against COVID-19 from the perspective of people who declined to get the shot.
|
|
Post-COVID Recovery Program Available for Patient Referrals
The RWJMS and Robert Wood Johnson University Hospital are collaborating on a joint Post-COVID Recovery Program to assist individuals after their bout with COVID.
The multidisciplinary program is led by Sabiha Hussain, MD, associate professor of medicine in the Division of Pulmonary and Critical Care, and offers a wide range of services.
Weekly clinics are hosted each Monday.
For more information or to schedule appointments, call the Post-COVID Recovery Program at 732-235-7840.
|
|
|
COVID-19 Research Studies
|
|
The New Jersey Alliance for Clinical and Translational Science compiled resources for translating COVID-19 from bench to bedside. Visit the site.
To learn more about funding opportunities and innovation challenges to assist the academic research community in mitigating COVID-19, click here.
RBHS is actively engaged in scientific discovery surrounding COVID-19. To learn more about the RBHS COVID-19 clinical trials, click here.
Check out the COVID-19 related research across the consortium.
Rutgers Awarded $5 Million NIH Grant to Improve Access to COVID-19 Testing. The New Jersey Alliance for Clinical and Translational Science received funding to launch outreach campaigns and expand access to testing for underserved and vulnerable communities in the state. The Rutgers-led study called the New Jersey Healthcare Essential Worker Outreach and Education Study – Testing Overlooked Occupations, or NJ HEROES TOO, is funded under NIH’s Rapid Acceleration of Diagnostics (RADx) initiative, RADx Underserved Populations (RADx-UP) program. The program supports research that aims to better understand COVID-19 testing patterns among underserved and vulnerable populations; strengthen the data on disparities in infection rates, disease progression, and outcomes; and develop strategies to reduce the disparities in COVID-19 testing, according to NIH. To read the full story.
The principal investigators of the Moderna and Johnson & Johnson COVID-19 vaccine clinical trials at Rutgers discuss how the university became a site, and their challenges and successes. In the race to develop a vaccine to battle the coronavirus, Rutgers has served as a site for Phase 3 COVID-19 clinical trials for two of the country’s pharmaceutical giants. Jeffrey Carson, a Distinguished Professor of Medicine at Rutgers Robert Wood Johnson Medical School and principal investigator at Rutgers for the Johnson & Johnson trial, and Shobha Swaminathan, associate professor of medicine at Rutgers New Jersey Medical School and clinical research site leader for the Moderna trial, discuss how the medical schools were selected and give an inside look at the process of creating a safe and effective vaccine. To read the full story.
Researchers Study Virus Evolution Trends Relevant for COVID-19 and Other Pandemics. One year after the first COVID-19 case was reported, researchers and medical professionals continue to learn more about the virus that causes it. Through a $188,253 National Science Foundation grant, Rutgers University‒Camden researcher Andrey Grigoriev is studying the RNA genome of the coronavirus behind COVID-19 – and trying to anticipate how to combat its mutations in the future. “Viruses undergo frequent mutations, and the worldwide effort of sequencing the RNA of thousands of coronavirus isolates allows us to analyze them using computational methods,” says Grigoriev, a Rutgers‒Camden professor of biology. “We search for the regions in the SARS-CoV-2 coronavirus genome that mutate rarely and try to understand what the reasons for such stability of these regions are.” To read the full story.
Neuroscience Professor Awarded NIH Grant to Study Links Between COVID-19 and Alzheimer’s. Mark Gluck, Professor of Neuroscience at the Center for Molecular & Behavioral Neuroscience (CMBN) at the School of Arts & Sciences-Newark, has received a new grant from the National Institutes of Health (NIH) to study the cognitive, neural, and immunological consequences of COVID-19 in older African Americans and how they relate to risk for Alzheimer’s Disease. With this grant, Gluck seeks to investigate the links between Alzheimer’s Disease and COVID-19, which share common immunological pathways and age-related risk. This is particularly critical for African Americans since they are known to be at elevated risk for age-related cognitive decline and Alzheimer’s Disease, and are also currently experiencing the highest overall COVID-19 mortality rates. Understanding how COVID-19 impacts cognition, neural function, and risk for Alzheimer’s may lead to new insights that inform clinically relevant future research on how age-related decline and dysfunction within the immune system may play a causal role in Alzheimer’s. To read the full story.
Rutgers Begins COVID-19 Prevalence Study in Newark. Rutgers will help determine the prevalence of the coronavirus in Newark, one of the cities hardest hit by the pandemic, as part of the National Institutes of Health COVID-19 Prevention Network (CoVPN) response to the deadly global outbreak. The university is one of 26 sites in the country chosen by the agency’s National Institute of Allergy and Infectious Diseases to conduct community seroprevalence studies. “There are still so many questions unanswered and things we have to discover in real time in relation to this pandemic,” said Shobha Swaminathan, clinical research site leader, Rutgers Research with a Heart and associate professor at the Rutgers New Jersey Medical School who will lead the study in Newark. Given that COVID-19 causes a lot of asymptomatic infections, this study will help us to better understand how the virus has impacted our community.” To read the full story.
|
|
We would like to share your resources with the community. Please email your information to njactscommunity@rjwms.rutgers.edu to contribute to our next Quarterly Newsletter issue.
|
|
Research Resources Workshop Wednesday (R2W2)
Every 2nd Wednesday 4-5pm
The Office of the Vice-Chancellor for Academic Affairs and Research announced their 2021 R2W2 Series, featuring shared resource core facilities available to Rutgers researchers. Learn more about these events here.
|
|
Free NIH Seminars for Clinical Researchers
Sex and Gender in Research
Interest in sex and gender in research—and resources to help investigators—is growing. In the 5 years since NIH enacted its pioneering Policy on Sex as a Biological Variable (SABV) there has been a lot of activity, including increased attention on sex differences and influences and many questions and requests for assistance.
|
|
We would like to share your events with the community. Please email your event details to njactscommunity@rjwms.rutgers.edu to contribute to our next Quarterly Newsletter issue.
|
|
New Jersey Alliance for Clinical and Translational Science
This newsletter is supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under award number, UL1TR003017 to Rutgers University. The content is solely the responsibility of the authors and does not represent the official views of the NIH.
You are receiving this newsletter because you are a member of NJ ACTS or have signed up to receive our emails.
To add a subscriber, please click here.
Send story ideas, events, and resources to njactscommunity@rwjms.rutgers.edu
Copyright 2021 New Jersey Alliance for Clinical and Translational Science, all rights reserved.
|
|
|
|
|
|
|
